We will be exploring the overlapping challenges and opportunities in collecting clinical data for registries, clinical trials and European Reference Networks (ERNs). George Reynolds, Rare Disease Specialist at Vitro Software will be co-hosting the webinar with Mark Krueger, Founder and Chief Strategy Officer of Mark Krueger & Associates and Kay Parkinson CEO of Cambridge Rare Disease Network.

Our annual newsletter looks back on 2017 and covers some of the highlights. We have been working with clients who include; Bendigo Health, Calvary Health Care, MyNetCare, The Nairobi Hospital, Biogen, Inc. SERCO, SEHA and more. From a product perspective the HTML5 front end of Vitro was launched enabling it to be accessible across a broader range of devices...

EUROPE’S MEETING PLACE FOR THE RARE DISEASE COMMUNITY. The 8th annual World Orphan Drug Congress is the marketplace for orphan drug professionals looking at the complete value chain of orphan drug development, from clinical development and R&D to corporate development and market access. George is chairing an interactive roundtable "Linking registries and clinical trials through ERNs: The paradigm shift in meeting Marketing Authorization requirements" @ 11.20 on November 15th

Vitro Software is a joint tender winner of rare disease software in the EU. The Clinical Patient Management System (CPMS) is a system to enable specialists from ERNs to exchange information to diagnose and treat patients. The European Commission has contracted OpenApp/Vitro to provide Software as a Service (SaaS) for the CPMS.